https://researchopenworld.com/social-media-controversy-affecting-the-introduction-of-hpv-vaccination-for-young-girls-in-cameroon/#

A. Amani, S. K. Nolna, Mireille Ndje Ndje, C. B. Ndongo, Marceline, Djuidje Ngounoue, B. A. Tiedeu, R. Leke
{"title":"https://researchopenworld.com/social-media-controversy-affecting-the-introduction-of-hpv-vaccination-for-young-girls-in-cameroon/#","authors":"A. Amani, S. K. Nolna, Mireille Ndje Ndje, C. B. Ndongo, Marceline, Djuidje Ngounoue, B. A. Tiedeu, R. Leke","doi":"10.31038/awhc.2019255","DOIUrl":null,"url":null,"abstract":"Cervical cancer is the second most frequent type of cancer in Cameroon [1]. More than 7.1 million Cameroonian women aged 15 and above are at risk of this disease [2]. In the past ten years, various pilot projects have demonstrated the efficacy and acceptability of Gardasil TM, the vaccine against Human Papillomavirus (HPV) [3,4]. Based on these successful demonstration phases, with the support of the Global Alliance for Vaccines and Immunization (GAVI), the HPV vaccine is finally being implemented countrywide by the Ministry of Public Health. The main objective of the vaccine roll-out will be to immunize at least 80% of 9-year-old girls, and thus reduce the morbidity and mortality due to cervical cancer and other HPV-related infections in Cameroon.","PeriodicalId":93266,"journal":{"name":"Archives of women health and care","volume":"18 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"https://researchopenworld.com/social-media-controversy-affecting-the-introduction-of-hpv-vaccination-for-young-girls-in-cameroon/#\",\"authors\":\"A. Amani, S. K. Nolna, Mireille Ndje Ndje, C. B. Ndongo, Marceline, Djuidje Ngounoue, B. A. Tiedeu, R. Leke\",\"doi\":\"10.31038/awhc.2019255\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Cervical cancer is the second most frequent type of cancer in Cameroon [1]. More than 7.1 million Cameroonian women aged 15 and above are at risk of this disease [2]. In the past ten years, various pilot projects have demonstrated the efficacy and acceptability of Gardasil TM, the vaccine against Human Papillomavirus (HPV) [3,4]. Based on these successful demonstration phases, with the support of the Global Alliance for Vaccines and Immunization (GAVI), the HPV vaccine is finally being implemented countrywide by the Ministry of Public Health. The main objective of the vaccine roll-out will be to immunize at least 80% of 9-year-old girls, and thus reduce the morbidity and mortality due to cervical cancer and other HPV-related infections in Cameroon.\",\"PeriodicalId\":93266,\"journal\":{\"name\":\"Archives of women health and care\",\"volume\":\"18 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-10-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archives of women health and care\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.31038/awhc.2019255\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of women health and care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31038/awhc.2019255","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

宫颈癌是喀麦隆第二常见的癌症类型[1]。超过710万15岁及以上的喀麦隆妇女有患此病的风险[2]。在过去的十年中,各种试点项目已经证明了Gardasil TM的有效性和可接受性,这是一种针对人乳头瘤病毒(HPV)的疫苗[3,4]。基于这些成功的示范阶段,在全球疫苗和免疫联盟(免疫联盟)的支持下,人乳头瘤病毒疫苗终于由公共卫生部在全国范围内实施。推广疫苗的主要目标将是为至少80%的9岁女孩进行免疫接种,从而降低喀麦隆宫颈癌和其他hpv相关感染的发病率和死亡率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
https://researchopenworld.com/social-media-controversy-affecting-the-introduction-of-hpv-vaccination-for-young-girls-in-cameroon/#
Cervical cancer is the second most frequent type of cancer in Cameroon [1]. More than 7.1 million Cameroonian women aged 15 and above are at risk of this disease [2]. In the past ten years, various pilot projects have demonstrated the efficacy and acceptability of Gardasil TM, the vaccine against Human Papillomavirus (HPV) [3,4]. Based on these successful demonstration phases, with the support of the Global Alliance for Vaccines and Immunization (GAVI), the HPV vaccine is finally being implemented countrywide by the Ministry of Public Health. The main objective of the vaccine roll-out will be to immunize at least 80% of 9-year-old girls, and thus reduce the morbidity and mortality due to cervical cancer and other HPV-related infections in Cameroon.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信